ING5 inhibits lung cancer invasion and epithelial–mesenchymal transition by inhibiting the WNT/β‐catenin pathway

Background ING5 is the last member of the Inhibitor of Growth (ING) candidate tumor suppressor family that has been implicated in multiple cellular functions, including cell cycle regulation, apoptosis, and chromatin remodeling. Our previous study showed that ING5 overexpression inhibits lung cancer...

Full description

Bibliographic Details
Main Authors: Xin‐Li Liu, Jin Meng, Xu‐Tao Zhang, Xiao‐Hua Liang, Feng Zhang, Guan‐Ren Zhao, Tao Zhang
Format: Article
Language:English
Published: Wiley 2019-04-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.13013
_version_ 1797845494469230592
author Xin‐Li Liu
Jin Meng
Xu‐Tao Zhang
Xiao‐Hua Liang
Feng Zhang
Guan‐Ren Zhao
Tao Zhang
author_facet Xin‐Li Liu
Jin Meng
Xu‐Tao Zhang
Xiao‐Hua Liang
Feng Zhang
Guan‐Ren Zhao
Tao Zhang
author_sort Xin‐Li Liu
collection DOAJ
description Background ING5 is the last member of the Inhibitor of Growth (ING) candidate tumor suppressor family that has been implicated in multiple cellular functions, including cell cycle regulation, apoptosis, and chromatin remodeling. Our previous study showed that ING5 overexpression inhibits lung cancer aggressiveness and epithelial–mesenchymal transition (EMT), with unknown mechanisms. Methods Western blotting was used to detect total and phosphorylated levels of β‐catenin and EMT‐related proteins. Immunofluorescent staining was used to observe E‐cadherin expression. Proliferation and colony formation, wound healing, and Transwell migration and invasion assays were performed to study the proliferative and invasive abilities of cancer cells. Results ING5 overexpression promotes phosphorylation of β‐catenin at Ser33/37, leading to a decreased β‐catenin protein level. Small hairpin RNA‐mediated ING5 knockdown significantly increased the β‐catenin level and inhibited phosphorylation of β‐catenin S33/37. Treatment with the WNT/β‐catenin inhibitor XAV939 inhibited ING5‐knockdown promoted proliferation, colony formation, migration, and invasion of lung cancer A549 cells, with increased phosphorylation of β‐catenin S33/37 and a decreased β‐catenin level. XAV939 also impaired ING5‐knockdown‐induced EMT, as indicated by upregulated expression of the EMT marker E‐cadherin, an epithelial marker; and decreased expression of N‐cadherin, a mesenchymal marker, and EMT‐related transcription factors, including Snail, Slug, Twist, and Smad3. Furthermore, XAV939 could inhibit the activation of both IL‐6/STAT3 and PI3K/Akt signaling pathways. Conclusion ING5 inhibits lung cancer invasion and EMT by inhibiting the WNT/β‐catenin pathway.
first_indexed 2024-04-09T17:39:57Z
format Article
id doaj.art-bd5d814bbe534d66b6ad96a37c59edc8
institution Directory Open Access Journal
issn 1759-7706
1759-7714
language English
last_indexed 2024-04-09T17:39:57Z
publishDate 2019-04-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj.art-bd5d814bbe534d66b6ad96a37c59edc82023-04-17T06:34:28ZengWileyThoracic Cancer1759-77061759-77142019-04-0110484885510.1111/1759-7714.13013ING5 inhibits lung cancer invasion and epithelial–mesenchymal transition by inhibiting the WNT/β‐catenin pathwayXin‐Li Liu0Jin Meng1Xu‐Tao Zhang2Xiao‐Hua Liang3Feng Zhang4Guan‐Ren Zhao5Tao Zhang6Department of Thoracic Surgery, Tangdu Hospital Fourth Military Medical University Xi'an ChinaDepartment of Pharmacology, School of Pharmacy Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine Fourth Military Medical University Xi'an ChinaDepartment of Pharmacology, School of Pharmacy Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine Fourth Military Medical University Xi'an ChinaDepartment of Thoracic Surgery, Tangdu Hospital Fourth Military Medical University Xi'an ChinaDepartment of Pharmacology, School of Pharmacy Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine Fourth Military Medical University Xi'an ChinaDepartment of Pharmacy PLA No. 309 Hospital Beijing ChinaDepartment of Thoracic Surgery, Tangdu Hospital Fourth Military Medical University Xi'an ChinaBackground ING5 is the last member of the Inhibitor of Growth (ING) candidate tumor suppressor family that has been implicated in multiple cellular functions, including cell cycle regulation, apoptosis, and chromatin remodeling. Our previous study showed that ING5 overexpression inhibits lung cancer aggressiveness and epithelial–mesenchymal transition (EMT), with unknown mechanisms. Methods Western blotting was used to detect total and phosphorylated levels of β‐catenin and EMT‐related proteins. Immunofluorescent staining was used to observe E‐cadherin expression. Proliferation and colony formation, wound healing, and Transwell migration and invasion assays were performed to study the proliferative and invasive abilities of cancer cells. Results ING5 overexpression promotes phosphorylation of β‐catenin at Ser33/37, leading to a decreased β‐catenin protein level. Small hairpin RNA‐mediated ING5 knockdown significantly increased the β‐catenin level and inhibited phosphorylation of β‐catenin S33/37. Treatment with the WNT/β‐catenin inhibitor XAV939 inhibited ING5‐knockdown promoted proliferation, colony formation, migration, and invasion of lung cancer A549 cells, with increased phosphorylation of β‐catenin S33/37 and a decreased β‐catenin level. XAV939 also impaired ING5‐knockdown‐induced EMT, as indicated by upregulated expression of the EMT marker E‐cadherin, an epithelial marker; and decreased expression of N‐cadherin, a mesenchymal marker, and EMT‐related transcription factors, including Snail, Slug, Twist, and Smad3. Furthermore, XAV939 could inhibit the activation of both IL‐6/STAT3 and PI3K/Akt signaling pathways. Conclusion ING5 inhibits lung cancer invasion and EMT by inhibiting the WNT/β‐catenin pathway.https://doi.org/10.1111/1759-7714.13013Epithelial–mesenchymal transition (EMT)ING5lung cancerphosphorylationWNT/β‐catenin
spellingShingle Xin‐Li Liu
Jin Meng
Xu‐Tao Zhang
Xiao‐Hua Liang
Feng Zhang
Guan‐Ren Zhao
Tao Zhang
ING5 inhibits lung cancer invasion and epithelial–mesenchymal transition by inhibiting the WNT/β‐catenin pathway
Thoracic Cancer
Epithelial–mesenchymal transition (EMT)
ING5
lung cancer
phosphorylation
WNT/β‐catenin
title ING5 inhibits lung cancer invasion and epithelial–mesenchymal transition by inhibiting the WNT/β‐catenin pathway
title_full ING5 inhibits lung cancer invasion and epithelial–mesenchymal transition by inhibiting the WNT/β‐catenin pathway
title_fullStr ING5 inhibits lung cancer invasion and epithelial–mesenchymal transition by inhibiting the WNT/β‐catenin pathway
title_full_unstemmed ING5 inhibits lung cancer invasion and epithelial–mesenchymal transition by inhibiting the WNT/β‐catenin pathway
title_short ING5 inhibits lung cancer invasion and epithelial–mesenchymal transition by inhibiting the WNT/β‐catenin pathway
title_sort ing5 inhibits lung cancer invasion and epithelial mesenchymal transition by inhibiting the wnt β catenin pathway
topic Epithelial–mesenchymal transition (EMT)
ING5
lung cancer
phosphorylation
WNT/β‐catenin
url https://doi.org/10.1111/1759-7714.13013
work_keys_str_mv AT xinliliu ing5inhibitslungcancerinvasionandepithelialmesenchymaltransitionbyinhibitingthewntbcateninpathway
AT jinmeng ing5inhibitslungcancerinvasionandepithelialmesenchymaltransitionbyinhibitingthewntbcateninpathway
AT xutaozhang ing5inhibitslungcancerinvasionandepithelialmesenchymaltransitionbyinhibitingthewntbcateninpathway
AT xiaohualiang ing5inhibitslungcancerinvasionandepithelialmesenchymaltransitionbyinhibitingthewntbcateninpathway
AT fengzhang ing5inhibitslungcancerinvasionandepithelialmesenchymaltransitionbyinhibitingthewntbcateninpathway
AT guanrenzhao ing5inhibitslungcancerinvasionandepithelialmesenchymaltransitionbyinhibitingthewntbcateninpathway
AT taozhang ing5inhibitslungcancerinvasionandepithelialmesenchymaltransitionbyinhibitingthewntbcateninpathway